Wuhan Keqian Biology Co.,Ltd released the third quarter report of 2024, achieving revenue of 0.666 billion yuan in the first three quarters, a decrease of 19.57% year-on-year; the net income attributable to shareholders of the listed company was 0.26 billion yuan, a decrease of 27.09% year-on-year. In the third quarter alone, revenue was 0.265 billion yuan, down 10.35% year-on-year; net income attributable to shareholders of the listed company was 0.108 billion yuan, a decrease of 8.68% year-on-year. The company stated that the decline in performance was mainly due to market conditions and the impact of non-epidemic factors, leading to a decline in sales volume and reduced revenue.
科前生物：前三季度净利润2.6亿元 同比下降27.09%
Wuhan Keqian Biology Co.,Ltd: The net income in the first three quarters was 0.26 billion yuan, a decrease of 27.09% year-on-year.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Investment Course
Choose stocks based on financial reports
Quickly master financial season learning guidelines
When the financial season comes, company stock prices are the most likely to rise and fall, and many excellent investors will see the financial season as a good
In 【2024.11】, surged more than 0.04 million times, achieving the title of stock god Buffett! How do you view Berkshire's performance?
When it comes to legendary figures in the investment world, the name of Warren Buffett, the helm of Berkshire Hathaway, is definitely unavoidable. $Berkshire Ha
【November 2024】Has disney's predicament turned around? Pay attention to these 3 performance signals.
As the entertainment kingdom for nearly a century, Disney's status in Hollywood has gained prominence. Over 60 years of listing on the U.S. stock market, Disney